Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases

Nathan A. Berger, Valerie C. Besson, A. Hamid Boulares, Alexander Bürkle, Alberto Chiarugi, Robert S. Clark, Nicola J. Curtin, Salvatore Cuzzocrea, Ted M. Dawson, Valina L. Dawson, György Haskó, Lucas Liaudet, Flavio Moroni, Pál Pacher, Peter Radermacher, Andrew L. Salzman, Solomon H. Snyder, Francisco Garcia Soriano, Robert P. Strosznajder, Balázs SümegiRaymond A. Swanson, Csaba Szabo

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases'. Together they form a unique fingerprint.

Medicine & Life Sciences